Search

Author/Creator Eom, Hyeon Seok

1. A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Issue 6 (2nd June 2016)

Authors:
Oh, Sung Yong; Kim, Won Seog; Kim, Jin Seok; Chae, Yee Soo; Lee, Gyeong-Won; Eom, Hyeon Seok; Ryoo, Hun Mo; Lee, Suee; Kim, Seok Jin; Yoon, Dok Hyun; Won, Jong Ho; Hong, Junshik; Park, Jinny; Lee, Sang-Min; Hong, Jung Yong; Park, Eunkyung; Kim, Hyo Jung; Yang, Deok-Hwan; Kim, Hyo-Jin; Suh, Cheolwon
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 6(2016:Jun.)
Page Start:
1406
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea. (4th June 2014)

Authors:
Lee, Ho Sup; Kim, Kihyun; Yoon, Dok Hyun; Kim, Jin Seok; Bang, Soo-Mee; Lee, Jeong-Ok; Eom, Hyeon Seok; Lee, Hyewon; Kim, Inho; Lee, Won Sik; Bae, Sung Hwa; Kim, Se Hyung; Lee, Mark Hong; Do, Young Rok; Lee, Jae Hoon; Hong, Junshik; Shin, Ho-Jin; Lee, Ji Hyun; Mun, Yeung-Chul; Min, Chang-Ki
Other Names:
Lee Dong Soon Academic Editor.
Journal:
BioMed research international
Issue:
Volume 2014(2014)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy. Issue 12 (8th September 2017)

Authors:
Cho, Hyungwoo; Yoon, Dok Hyun; Lee, Jung Bok; Kim, Sung‐Yong; Moon, Joon Ho; Do, Young Rok; Lee, Jae Hoon; Park, Yong; Lee, Ho Sup; Eom, Hyeon Seok; Shin, Ho‐Jin; Min, Chang‐Ki; Kim, Jin Seok; Jo, Jae‐Cheol; Kang, Hye Jin; Mun, Yeung‐Chul; Lee, Won Sik; Lee, Je‐Jung; Suh, Cheolwon; Kim, Kihyun
Journal:
American journal of hematology
Issue:
Volume 92:Issue 12(2017:Dec.)
Page Start:
1280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma. Issue 2 (28th January 2015)

Authors:
Goh, Ah Ra; Shin, Seung-Pil; Jung, Na-Rae; Ryu, Chang-Hwan; Eom, Hyeon Seok; Lee, John H.; Choi, Kyungho; Lee, Sang-Jin; Jung, Yuh-S.
Journal:
Cancer letters
Issue:
Volume 356:Issue 2(2015)Part B
Page Start:
743
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma. Issue 2 (28th January 2015)

Authors:
Goh, Ah Ra; Shin, Seung-Pil; Jung, Na-Rae; Ryu, Chang-Hwan; Eom, Hyeon Seok; Lee, John H.; Choi, Kyungho; Lee, Sang-Jin; Jung, Yuh-S.
Journal:
Cancer letters
Issue:
Volume 356:Issue 2(2015)Part B
Page Start:
743
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗